Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
New treatment more than doubles survival for high risk childhood leukemia
EurekAlert, 10/07/09
Results of a phase two clinical trial show that adding continuous daily doses of a targeted drug called imatinib mesylate to regular chemotherapy more than doubled three–year survival rates for children with a high risk type of blood cancer called Philadelphia chromosome–positive acute lymphoblastic leukemia.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Study identifies those elderly most at risk for major depression
EurekAlert, 12/18/09
Negative emotions outweigh intent to exercise at health clubs
ScienceDaily, 12/18/09
Stratifying breast cancer without biopsy: Researchers identify possible imaging method
ScienceDaily, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


